James Antony Brannigan

Title: James Antony Brannigan: Innovator in Medicinal Chemistry

Introduction

James Antony Brannigan is a notable inventor based in York, GB. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on inhibitors of N-myristoyl transferase. With a total of 2 patents to his name, Brannigan's inventions hold promise for treating various diseases.

Latest Patents

Brannigan's latest patents focus on compounds that serve as inhibitors of N-myristoyl transferase (NMT). These compounds, described by a specific formula, have shown potential as medicaments. They are particularly relevant in the treatment of diseases where inhibition of NMT can provide therapeutic or prophylactic effects. This includes conditions such as protozoan infections like malaria and leishmaniasis, viral infections such as human rhinovirus and HIV, and hyperproliferative disorders like B-cell lymphoma.

Career Highlights

Brannigan is associated with Imperial College Innovations Limited, where he continues to advance his research and development efforts. His work is characterized by a commitment to addressing significant health challenges through innovative solutions.

Collaborations

Brannigan has collaborated with notable colleagues, including Andrew Simon Bell and Edward William Tate. These partnerships have likely contributed to the depth and impact of his research.

Conclusion

James Antony Brannigan stands out as an influential inventor in the realm of medicinal chemistry. His work on N-myristoyl transferase inhibitors showcases his dedication to developing effective treatments for serious health conditions.